Procalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis

Critical Care Research and Practice

Volumn 2014, Issue , 2014, Pages

  Mat Nor, Mohd Basri ^a   Md Ralib, Azrina ^a  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897896214     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2014/819034     Document Type: Article

References (33)

1. Wolff M., Bouadma L., What procalcitonin brings to management of sepsis in the ICU. Critical Care 2010 14 6, article 1007 2-s2.0-79955607098 10.1186/cc9330
2. Bouadma L., Luyt C.-E., Tubach F., Cracco C., Alvarez A., Schwebel C., Schortgen F., Lasocki S., Veber B., Dehoux M., Bernard M., Pasquet B., Régnier B., Brun-Buisson C., Chastre J., Wolff M., Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. The Lancet 2010 375 9713 463 474 2-s2.0-75949113583 10.1016/S0140-6736(09)61879-1
3. Matthaiou D. K., Ntani G., Kontogiorgi M., Poulakou G., Armaganidis A., Dimopoulos G., An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Medicine 2012 38 940 949 2-s2.0-84860109664 10.1007/s00134-012-2563-7
4. Soni N. J., Samson D. J., Galaydick J. L., Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. Journal of Hospital Medicine 2013 8 9 530 540
5. Hohn A., Schroeder S., Gehrt A., Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infectious Diseases 2013 13 158 10.1186/1471-2334-13-158
6. Castelli G. P., Pognani C., Meisner M., Stuani A., Bellomi D., Sgarbi L., Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Critical Care 2004 8 4 R234 R242 2-s2.0-13844288894
7. Reinhart K., Meisner M., Biomarkers in the critically Ill patient: procalcitonin. Critical Care Clinics 2011 27 2 253 263 2-s2.0-79953001345 10.1016/j.ccc.2011.01.002
8. Meisner M., Tschaikowsky K., Palmaers T., Schmidt J., Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Critical Care 1999 3 1 45 50 2-s2.0-0033010263 10.1186/cc306 (Pubitemid 29304058)
9. Vincent J.-L., Sakr Y., Sprung C. L., Ranieri V. M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.-R., Payen D., Sepsis in European intensive care units: results of the SOAP study. Critical Care Medicine 2006 34 2 344 353 2-s2.0-31344461826 10.1097/01.CCM.0000194725.48928.3A (Pubitemid 43145611)
10. Viallon A., Guyomarc'h S., Marjollet O., Berger C., Carricajo A., Robert F., Laporte S., Lambert C., Page Y., Zéni F., Bertrand J. C., Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. European Journal of Emergency Medicine 2008 15 1 26 33 2-s2.0-37849052183 10.1097/MEJ.0b013e3280ec539b
11. Tang B. M., Eslick G. D., Craig J. C., McLean A. S., Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infectious Diseases 2007 7 3 210 217 2-s2.0-33847056146 10.1016/S1473-3099(07)70052-X (Pubitemid 46274517)
12. Karlsson S., Heikkinen M., Pettilä V., Alila S., Väisänen S., Pulkki K., Kolho E., Ruokonen E., Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Critical Care 2010 14 6, article R205 2-s2.0-78149425934 10.1186/cc9327
13. Meng F.-S., Su L., Tang Y.-Q., Wen Q., Liu Y.-S., Liu Z.-F., Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clinical Biochemistry 2009 42 10-11 1025 1031 2-s2.0-67349127628 10.1016/j.clinbiochem.2009.03.012
14. Tschaikowsky K., Hedwig-Geissing M., Braun G. G., Radespiel-Troeger M., Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. Journal of Critical Care 2011 26 1 54 64 2-s2.0-79551519906 10.1016/j.jcrc.2010.04.011
15. Seligman R., Meisner M., Lisboa T. C., Hertz F. T., Filippin T. B., Fachel J. M. G., Teixeira P. J. Z., Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Critical Care 2006 10 5, article R125 2-s2.0-33847755676 10.1186/cc5036 (Pubitemid 47079171)
16. Luyt C.-E., Guérin V., Combes A., Trouillet J.-L., Ayed S. B., Bernard M., Gibert C., Chastre J., Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2005 171 1 48 53 2-s2.0-11144234176 10.1164/rccm.200406- 746OC (Pubitemid 40051694)
17. Jensen J. U., Heslet L., Jensen T. H., Espersen K., Steffensen P., Tvede M., Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Critical Care Medicine 2006 34 10 2596 2602 2-s2.0-33748782250 10.1097/01.CCM.0000239116.01855.61 (Pubitemid 44413058)
18. Ruiz-Rodríguez J. C., Caballero J., Ruiz-Sanmartin A., Ribas V. J., Pérez M., Bóveda J. L., Rello J., Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study. Medicina Intensiva 2012 36 475 480 2-s2.0-84855736553 10.1016/j.medin.2011.11. 024
19. Suberviola B., Castellanos-Ortega A., González-Castro A., García-Astudillo L. A., Fernández-Miret B., Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock. Medicina Intensiva 2012 36 3 177 184 2-s2.0-84859163676 10.1016/j.medin.2011.09.008
20. Bone R. C., Balk R. A., Cerra F. B., American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992 20 864 874 10.1097/00003246-199206000- 00025
21. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J.-L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B (Pubitemid 36444440)
22. Kumar R., Indrayan A., Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatrics 2011 48 4 277 287 2-s2.0-79958084913 10.1007/s13312-011-0055-4
23. Dellinger R. P., Levy M. M., Carlet J. M., Hora P., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine 2008 Springer 296 327
24. Guan J., Lin Z., Lue H., Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng/mL. Shock 2011 36 6 570 574 2-s2.0-81755166344 10.1097/SHK. 0b013e31823533f9
25. Claeys R., Vinken S., Spapen H., Ver Elst K., Decochez K., Huyghens L., Gorus F. K., Plasma procalcitonin and c-reactive protein in acute septic shock: clinical and biological correlates. Critical Care Medicine 2002 30 4 757 762 2-s2.0-0036215517 (Pubitemid 34297790)
26. Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001 29 7 1303 1310 2-s2.0-0034958947 (Pubitemid 32641789)
27. Dellinger R. P., Levy M. M., Rhodes A., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine 2013 41 580 637 10.1097/CCM.0b013e31827e83af
28. Geok J. T. M., Ling T. L., Cheng T. C., Malaysian Registry of Intensive Care Report 2012. www.mric.org.my
29. Kumar A., Roberts D., Wood K. E., Light B., Parrillo J. E., Sharma S., Suppes R., Feinstein D., Zanotti S., Taiberg L., Gurka D., Kumar A., Cheang M., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine 2006 34 6 1589 1596 2-s2.0-33744527833 10.1097/01.CCM.0000217961.75225. E9 (Pubitemid 43810035)
30. Charles P. E., Tinel C., Barbar S., Aho S., Prin S., Doise J. M., Olsson N. O., Blettery B., Quenot J. P., Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Critical Care 2009 13 2, article R38 2-s2.0-64049119735 10.1186/cc7751
31. Schuetz P., Maurer P., Punjabi V., Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Critical Care 2013 17 3 R115
32. Georgopoulou A.-P., Savva A., Giamarellos-Bourboulis E. J., Georgitsi M., Raftogiannis M., Antonakos N., Apostolidou E., Carrer D.-P., Dimopoulos G., Economou A., Efthymiou G., Galanakis N., Galani L., Gargalianos P., Karaiskos I., Katsenos C., Kavatha D., Koratzanis E., Labropoulos P., Lada M., Nakos G., Paggalou E., Panoutsopoulos G., Paraschos M., Pavleas I., Pontikis K., Poulakou G., Prekates A., Sybardi S., Theodorakopoulou M., Trakatelli C., Tsiaoussis P., Gogos C., Giamarellou H., Armaganidis A., Meisner M., Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. Journal of Critical Care 2011 26 3 331 e1 e7 2-s2.0-79956340905 10.1016/j.jcrc.2010.07.012
33. Jones A. E., Trzeciak S., Kline J. A., The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Critical Care Medicine 2009 37 5 1649 1654 2-s2.0-67649945779 10.1097/CCM.0b013e31819def97